Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases

NCT04946916 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT04946916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04946916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Serum Neurofilament Light Chain as a Biomarker to Differentiate Cognitive Impairment From Neurodegenerative or Psychiatric Diseases
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Recruiting
Start date
October 22, 2021
Completion date
March 22, 2028
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, bipolar disorder, ftd, schizophrenia